Abstract:The incidence of pancreatic carcinoma, a gastrointestinal malignancy, is on the increase and effective therapeutic strategies are therefore required. This study aimed to construct a recombinant plasmid pcDNA3.1(-) shCEACAM6-yCDglyTK from CEACAM6 targeting shRNA and the fusion suicide gene yCDglyTK for inhibition of SW 1990 human pancreatic carcinoma cell growth and invasion. A plasmid containing hU6 promoter and CEACAM6 targeting short hairpin RNA (CEACAM6-shRNA) frame was constructed. It was subcloned to a CEA promoter-driven fusion suicide gene pcDNA3.1(-)yCDglyTK. The recombinant plasmid pcDNA3.1(-)shCEACAM6-yCDglyTK was identified by restriction endonuclease analysis and DNA sequencing. The recombinant plasmid was delivered into SW 1990 human pancreatic carcinoma cells, the mRNA and protein expression of yCDglyTK and CEACAM6 was examined by RT-PCR, western blot analysis and immunofluorescence. SW 1990 cells were treated with the prodrug 5-fluorocytosine (5-FC), and the cell viability was evaluated using the 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyl tetrazolium bromide (MTT) assay. The invasiveness and migration of SW 1990 cells were evaluated by transwell migration assays. The restriction endonuclease analysis and DNA sequencing confirmed the construction of the recombinant plasm id pcDNA3.1(-)shCEACAM6-yCDglyTK. Reverse transcription polymerase chain reaction (RT-PCR) and western blot analysis outcomes showed that yCDglyTK was expressed in SW1990 cells and expression of CEACAM6 in SW1990 cells was significantly knocked down. MTT assay showed that the mean viability of SW1990 cells was significantly reduced after administration of the prodrug 5-FC in vitro. Transwell migration assays showed that invasion and migration action of SW1990 cells was significantly inhibited. In conclusion, recombinant plasmid pcDNA3.1(-) shCEACAM6-yCDglyTK was successfully constructed. The recombinant plasmid may therefore serve as a novel gene therapy approach for pancreatic carcinoma.

Construction of combined gene vector of carcinoembryonic antigen associated cell adhesion molecule 6(CEACAM6)-shRNA and double suicide gene of yCDglyTK

Construction of Combination Gene Vector Expressing VEGF-siRNA and Fusion Suicide Gene Ycdglytk and Its Application

Construction of Eukaryotic Expression Fusion Plasmid of HPV6b E7 Gene and CRT Gene

Construction of carcino-embryonic antigen promotor controls the novel fusion suicide gene yCDglyTK and its application

Effective Combination Gene Therapy Using CEACAM6-shRNA and the Fusion Suicide Gene Ycdglytk for Pancreatic Carcinoma in Vitro

[A Preliminary Study on Construction of Targeting Double Suicide Gene Therapy Vector Pcdna3.1 (-) Cp-CD-TK].

Construction of Calcium Phosphate Nanoparticles Mediating Fusion Suicide Gene yCDglyTK and its Application in vitro

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Construction of Hepatocellular Carcinoma-Specific Eukarotypic Expression Vector Carrying Double Suicide Genes

Cloning of SARS-CoV-S Gene and Construction of Its Short Interfering RNAs Expression Vector

[Construction of the Recombinant Adenovirus Vector Bearing Dual-Survivin Shrna].

Construction and verification of a novel single targeted CRAd shuttle vector pshuttle-E1A-E1Bp-E1B55K

Construction and Identification of the Eukaryotic Expression Vector Expressing Short Hairpin RNA Targeting Human CD146

Construction of a Novel Vector Expressing Survivin-shRNA and Fusion Suicide Gene Ycdglytk and Its Application in Inhibiting Proliferation and Migration of Colon Cancer Cells

Antitumor Effects of Recombinant Vectors Carrying CDglyTK Suicide Gene on Nasopharyngeal Carcinoma Cell in Vitro

[Transcriptional Targeting Gene Therapy of Double Suicide Gene Driven by Htert Promoter in Hepatic Carcinoma].

Construction of targeted plasmid vector pcDNA3.1(-)CMV·Egr-1CDglyTK and its transfection into nasopharyngeal carcinoma cell

[Construction and Functional Analysis of a Common Gene Targeting Vector with Double-Selection Markers].

Construction of the recombinant adenovirus vector with eGFR antisense cDNA of controlling cell cycle

Gene cloning and identification of shCD40L- IRES2-CTLA4Ig recombination adenovirus vector and exprssion in vitro

Construction of Recombination Expression Vector Pires-Cd and Pires-Tk and Their Expressions in ACC-2 Cells